Latest Announcements

While registering for the 8th Annual Conference of the ISSLC (NALCCON 2017) being held in conjunction with the 2nd Indian Cancer Congress, ISSLC members need to register for 2 days (9th and 10th November) to have access to the ICC tracks (forenoon sessions) as well as the ISSLC sessions (afternoon) on these days. Please quote your ISSLC membership number to get discounted rates for registration.

NALCCON 2017 (8th Annual Conference of the Indian Society for Study of Lung Cancer) will be organized on the sidelines of the 2nd Indian Cancer Congress at Bengaluru, Karnataka (November 08-12, 2017; www.indiancancercongress2017.com). The ISSLC is proud to be a partner organization for the 2nd ICC.


The ISSLC is pleased to announce that as a result of the encouraging feedback received from the previous two versions of ASCO-ISSLC Lung Multidisciplinary Cancer Management Course (MCMC) - held at PGIMER, Chandigarh (April 2014) and at Tata Memorial Hospital, Mumbai (March 2016), the 3rd version of this ASCO-ISSLC Lung MCMC will be held on 24-25 March, 2018 at PGIMER, Chandigarh. The highlight of this course, as for the previous 2 courses, would be a focus on multidisciplinary management of lung cancer and in particular, case discussions by multidisciplinary tumor boards comprised of the international (ASCO) faculty (please click on this message) as well as eminent national faculty (including those from the two collaborating institutes - PGIMER, Chandigarh and Tata Memorial Hospital, Mumbai). Further details will be uploaded on ISSLC and ASCO websites in due course of time.


Young Investigator Award for NALCCON 2017


IMPORTANT NOTICE regarding updating of emails: please click on this message

Welcome to ISSLC


Lung cancer is an important cause of mortality and morbidity world over. Its incidence continues to rise in India and other developing countries. Despite advances in early detection, diagnosis and treatment, the overall survival and outcomes for lung cancer have not changed substantially over the years. Although tobacco smoking remains the most important risk factor for development of lung cancer, association of indoor/outdoor air pollution, occupational exposures and genetic factors with development of this disease has been identified especially amongst non-smokers. A greater understanding of the molecular basis of lung cancer has occurred in the past two decades and has paved the way for development of molecularly targeted therapies which has revolutionized the management of this disease.

The ISSLC (Indian Society for Study of Lung Cancer) continues to be the only professional body in India that is dedicated to the advancement of lung cancer research, education and advocacy. Its membership is open to medical, surgical and radiation oncologists, pulmonologists, physicians, oncology nurses and other volunteers who have the dedication to work together towards achieving the goal of reducing suffering from lung cancer in India.